Nuvation Bio earnings were -$606.4M for the trailing 12 months ending Mar 31, 2025, with N/A growth year over year. The latest NUVB earnings report on Mar 31, 2025 announced Q1 2025 earnings of -$53.2M, up 7.7% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, NUVB reported annual earnings of -$567.9M, with 649.2% growth.
On NUVB's earnings call on Invalid Date, Nuvation Bio (NYSE: NUVB) reported Q1 2025 earnings per share (EPS) of -$0.16, up 128.57% year over year. Total NUVB earnings for the quarter were -$53.24 million. In the same quarter last year, Nuvation Bio's earnings per share (EPS) was -$0.07.
As of the last Nuvation Bio earnings report, Nuvation Bio is currently losing money. Nuvation Bio's net profit (also called net income) for the twelve months ending Mar 31, 2025 was -$606.38 million, a 780.5% increase year over year.
What was NUVB's earnings growth in the past year?
As of Nuvation Bio's earnings date in Invalid Date, Nuvation Bio's earnings has grown year over year. NUVB earnings in the past year totalled -$606.38 million.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.